Radiation safety considerations for the use of radium-224-calciumcarbonate-microparticles in patients with peritoneal metastasis.

Grønningsæter SR, Blakkisrud J, Selboe S, Revheim ME, Bruland ØS, Bønsdorff TB, Larsen SG, Stokke C.

Open source

DOI
10.3389/fmed.2023.1058914
Published
2023-02-08
Container
Front Med (Lausanne)
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2023.1058914,
  title = {Radiation safety considerations for the use of radium-224-calciumcarbonate-microparticles in patients with peritoneal metastasis.},
  author = {Grønningsæter SR and  Blakkisrud J and  Selboe S and  Revheim ME and  Bruland ØS and  Bønsdorff TB and  Larsen SG and  Stokke C.},
  year = {2023},
  journal = {Front Med (Lausanne)},
  doi = {10.3389/fmed.2023.1058914},
  url = {https://doi.org/10.3389/fmed.2023.1058914}
}

RIS

TY  - JOUR
TI  - Radiation safety considerations for the use of radium-224-calciumcarbonate-microparticles in patients with peritoneal metastasis.
AU  - Grønningsæter SR
AU  -  Blakkisrud J
AU  -  Selboe S
AU  -  Revheim ME
AU  -  Bruland ØS
AU  -  Bønsdorff TB
AU  -  Larsen SG
AU  -  Stokke C.
PY  - 2023
JO  - Front Med (Lausanne)
DO  - 10.3389/fmed.2023.1058914
UR  - https://doi.org/10.3389/fmed.2023.1058914
ER  - 

APA

SR, G., J, B., S, S., ME, R., ØS, B., TB, B., SG, L., & C., S. (2023). Radiation safety considerations for the use of radium-224-calciumcarbonate-microparticles in patients with peritoneal metastasis.. Front Med (Lausanne). https://doi.org/10.3389/fmed.2023.1058914

Source records